The combination of SZ-A or Met with premixed insulin not only improved blood glucose control, but also reduced blood glucose fluctuations and blood lipid indicators in our cohort of patients with T2DM whose blood glucose levels could not be controlled through the use of oral medications. The gene discussed is INS; the disease is type 2 diabetes mellitus.